Literature DB >> 17143961

A series of 64 cases of pancreatic cystic neoplasia from an institutional study of China.

Yuan Ji1, Wen-Hui Lou, Da-Yong Jin, Tian-Tao Kuang, Meng-Su Zeng, Yun-Shan Tan, Hai-Ying Zeng, Akesu Sujie, Xiong-Zeng Zhu.   

Abstract

AIM: To recognize cystic neoplasia of the pancreas and thus to identify a panel of curable diseases.
METHODS: Sixty-four cases of cystic neoplasia of the pancreas, including 28 cases of intraductal papillary mucinous neoplasia (IPMN), 12 cases of serous cystic neoplasia (SCN), 11 cases of mucinous cystic neoplasia (MCN), 11 cases of solid pseudo-papillary neoplasia (SPN), and 2 cases of solid tumor with cystic degeneration were examined immunohistochemically for their expression of MUC1, MUC2, MUC4, MUC5AC, and MUC6, as well as other related antigens.
RESULTS: Adenoma type of IPMN and borderline lesions exhibited high expressions of MUC2, and MUC5AC. In contrast, IPMN with invasive carcinoma component showed MUC1 immunoreactivity. SCN was mainly positive for MUC1 and MUC6, while negative for MUC2, MUC4 and MUC5AC. Noninvasive MCN, regardless of its cellular atypia degree, was positive for MUC5AC and negative for MUC1. MUC1 expression was only observed in patients with an invasive component. No mucin expression was found in SPN.
CONCLUSION: Mucin profile may, in conjunction with histologic study, provide important information on tumor types and patient treatment of cystic neoplasia of the pancreas.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17143961      PMCID: PMC4087503          DOI: 10.3748/wjg.v12.i45.7380

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  21 in total

1.  The mucin profile of noninvasive and invasive mucinous cystic neoplasms of the pancreas.

Authors:  J Lüttges; B Feyerabend; T Buchelt; M Pacena; G Klöppel
Journal:  Am J Surg Pathol       Date:  2002-04       Impact factor: 6.394

2.  Pancreatic ductal adenocarcinomas with cystic features: neither rare nor uniform.

Authors:  Markus Kosmahl; Ursula Pauser; Martin Anlauf; Günter Klöppel
Journal:  Mod Pathol       Date:  2005-09       Impact factor: 7.842

3.  The epidermal growth factor receptor regulates interaction of the human DF3/MUC1 carcinoma antigen with c-Src and beta-catenin.

Authors:  Y Li; J Ren; W Yu; Q Li; H Kuwahara; L Yin; K L Carraway; D Kufe
Journal:  J Biol Chem       Date:  2001-08-01       Impact factor: 5.157

4.  WHO-classification 2000: exocrine pancreatic tumors.

Authors:  G Klöppel; J Lüttges
Journal:  Verh Dtsch Ges Pathol       Date:  2001

5.  MUC1 and MUC2 expression in pancreatic ductal carcinoma obtained by fine-needle aspiration.

Authors:  David C Chhieng; Elizabeth Benson; Isam Eltoum; Mohamad A Eloubeidi; Nirag Jhala; Darshana Jhala; Gene P Siegal; William E Grizzle; Upender Manne
Journal:  Cancer       Date:  2003-12-25       Impact factor: 6.860

6.  Serous cystic neoplasms of the pancreas: an immunohistochemical analysis revealing alpha-inhibin, neuron-specific enolase, and MUC6 as new markers.

Authors:  Markus Kosmahl; Janning Wagner; Katharina Peters; Bence Sipos; Günter Klöppel
Journal:  Am J Surg Pathol       Date:  2004-03       Impact factor: 6.394

Review 7.  MUC1 and MUC2 in pancreatic neoplasia.

Authors:  E Levi; D S Klimstra; A Andea; O Basturk; N V Adsay
Journal:  J Clin Pathol       Date:  2004-05       Impact factor: 3.411

8.  The expression of several types of mucin is related to the biological behavior of pancreatic neoplasms.

Authors:  Suguru Yonezawa; Akiko Nakamura; Michiko Horinouchi; Eiichi Sato
Journal:  J Hepatobiliary Pancreat Surg       Date:  2002

9.  Expression of gastric gland mucous cell-type mucin in normal and neoplastic human tissues.

Authors:  Kosei Nakajima; Hiroyoshi Ota; Mu Xia Zhang; Kenji Sano; Takayuki Honda; Keiko Ishii; Jun Nakayama
Journal:  J Histochem Cytochem       Date:  2003-12       Impact factor: 2.479

10.  Pancreatic mucinous noncystic (colloid) carcinomas and intraductal papillary mucinous carcinomas are usually microsatellite stable.

Authors:  Jutta Lüttges; Kurt Beyser; Susanne Pust; Anja Paulus; Josef Rüschoff; Günter Klöppel
Journal:  Mod Pathol       Date:  2003-06       Impact factor: 7.842

View more
  5 in total

1.  Genetic markers of malignant transformation in intraductal papillary mucinous neoplasm of the pancreas: a meta-analysis.

Authors:  Sahar Nissim; Gregory E Idos; Bechien Wu
Journal:  Pancreas       Date:  2012-11       Impact factor: 3.327

2.  Mucin 5AC expression is common but unrelated to tumor progression in pancreatic adenocarcinoma.

Authors:  Sebastian Dwertmann Rico; Franziska Büscheck; David Dum; Andreas M Luebke; Martina Kluth; Claudia Hube-Magg; Andrea Hinsch; Doris Höflmayer; Daniel Perez; Jakob R Izbicki; Michael Neipp; Hamid Mofid; Thies Daniels; Christoph Isbert; Christoph Fraune; Katharina Möller; Anne Menz; Christian Bernreuther; Patrick Lebok; Till Clauditz; Guido Sauter; Ria Uhlig; Waldemar Wilczak; Ronald Simon; Stefan Steurer; Eike Burandt; Andreas Marx; Till Krech
Journal:  Int J Immunopathol Pharmacol       Date:  2022 Jan-Dec       Impact factor: 3.298

3.  Differentiating pancreatic ductal adenocarcinoma from pancreatic serous cystadenoma, mucinous cystadenoma, and a pseudocyst with detailed analysis of cystic features on CT scans: a preliminary study.

Authors:  Peijie Lv; Radfan Mahyoub; Xiaozhu Lin; Kemin Chen; Weimin Chai; Jing Xie
Journal:  Korean J Radiol       Date:  2011-03-03       Impact factor: 3.500

Review 4.  Management of Incidental Pancreatic Cystic Lesions.

Authors:  Christian Jenssen; Stefan Kahl
Journal:  Viszeralmedizin       Date:  2015-02

5.  Surgical resection and outcome of pancreatic cystic neoplasms in China: analysis of a 16-year experience from a single high-volume academic institution.

Authors:  Xueli Bai; Longyun Ye; Qi Zhang; Pankaj Prasoon; Ji Wang; Tingbo Liang
Journal:  World J Surg Oncol       Date:  2014-07-19       Impact factor: 2.754

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.